These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17168853)

  • 1. The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy.
    Wilkinson-Berka JL; Wraight C; Werther G
    Curr Med Chem; 2006; 13(27):3307-17. PubMed ID: 17168853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy.
    Poulaki V; Joussen AM; Mitsiades N; Mitsiades CS; Iliaki EF; Adamis AP
    Am J Pathol; 2004 Aug; 165(2):457-69. PubMed ID: 15277220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of diabetic retinopathy with somatostatin analogues].
    Lang GE
    Ophthalmologe; 2004 Mar; 101(3):290-3. PubMed ID: 15007609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin analogues may accelerate progression of diabetic retinopathy after impairment of inner blood-retinal barrier.
    Kaya A; Kar T; Aksoy Y; Özalper V; Başbuğ B
    Med Hypotheses; 2013 Dec; 81(6):1012-4. PubMed ID: 24090664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of retinal endothelial cell behaviour by insulin-like growth factor I and somatostatin analogues: implications for diabetic retinopathy.
    Wilson SH; Davis MI; Caballero S; Grant MB
    Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S53-9. PubMed ID: 11527089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin, growth hormone, insulin-like growth factor-1, and diabetes: friends or foes?
    Orskov H
    Metabolism; 1996 Aug; 45(8 Suppl 1):91-5. PubMed ID: 8769394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
    Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
    J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factors and diabetic retinopathy.
    Paques M; Massin P; Gaudric A
    Diabetes Metab; 1997 Apr; 23(2):125-30. PubMed ID: 9137900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin analogues as drug therapies for retinopathies.
    Grant MB; Caballero S
    Drugs Today (Barc); 2002 Nov; 38(11):783-91. PubMed ID: 12582462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?
    Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF
    Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus and retinopathy.
    Gargiulo P; Giusti C; Pietrobono D; La Torre D; Diacono D; Tamburrano G
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S101-5. PubMed ID: 15077918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiogenic growth factor combinations on retinal endothelial cells.
    Castellon R; Hamdi HK; Sacerio I; Aoki AM; Kenney MC; Ljubimov AV
    Exp Eye Res; 2002 Apr; 74(4):523-35. PubMed ID: 12076096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic problem of proliferative diabetic retinopathy: targeting somatostatin receptors.
    Davis MI; Wilson SH; Grant MB
    Horm Metab Res; 2001 May; 33(5):295-9. PubMed ID: 11440276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
    Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
    Gacka M; Adamiec J
    Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization.
    Kondo T; Vicent D; Suzuma K; Yanagisawa M; King GL; Holzenberger M; Kahn CR
    J Clin Invest; 2003 Jun; 111(12):1835-42. PubMed ID: 12813019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of growth hormone in ischemia-induced retinal neovascularization.
    Smith LE; Kopchick JJ; Chen W; Knapp J; Kinose F; Daley D; Foley E; Smith RG; Schaeffer JM
    Science; 1997 Jun; 276(5319):1706-9. PubMed ID: 9180082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.
    Burgos R; Mateo C; Cantón A; Hernández C; Mesa J; Simó R
    Diabetes Care; 2000 Jan; 23(1):80-3. PubMed ID: 10857973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
    Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
    Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
    Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
    Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.